ICAM-1 is required for resistance to herpes simplex virus type 1 but not interferon-α1 transgene efficacy

被引:5
|
作者
Noisakran, S
Härle, P
Carr, DJJ
机构
[1] Univ Oklahoma, Dept Ophthalmol, Dean McGee Eye Inst, OUHSC, Oklahoma City, OK 73104 USA
[2] Univ Oklahoma, Dept Ophthalmol, Dept Microbiol & Immunol, Oklahoma City, OK 73104 USA
关键词
HSV-1; ICAM-1; IFN-alpha; plasmid DNA; cytokine;
D O I
10.1006/viro.2001.0858
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The purpose of this study was to determine the role of ICAM-1 in ocular herpes simplex virus type 1 (HSV-1) infection. Wild-type and ICAM-1 knockout mice were assessed for resistance to ocular HSV-1 infection in the presence of naked DNA plasmid vector or plasmid DNA encoding interferon-alpha1 topically applied to the cornea of the mice. Wild-type mice showed greater resistance to HSV-1 infection compared to ICAM-1 knockout mice as measured by cumulative survival. The absence of ICAM-1 did not affect the efficacy of the interferon-al transgene against ocular HSV-1. Both ICAM-1 and wild-type mice treated with the transgene showed a reduction in viral load and antigen expression in the trigeminal ganglion compared to the plasmid vector-treated counterparts. In contrast, the presence of the transgene reduced the number of infiltrating cells into the cornea in comparison to plasmid vector DNA controls in the wild-type mice but not in the ICAM-1 knockout mice. Collectively, these results suggest that the IFN-alpha1 transgene can restore resistance against HSV-1 infection in ICAM-1-deficient mice. (C) 2001 Academic Press.
引用
收藏
页码:69 / 77
页数:9
相关论文
共 50 条
  • [1] Role of Us3 gene of herpes simplex virus type 1 for resistance to interferon
    Piroozmand, A
    Koyama, AH
    Shimada, Y
    Fujita, M
    Arakawa, T
    Adachi, A
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2004, 14 (04) : 641 - 645
  • [2] Interferon-β suppresses herpes simplex virus type 1 replication in trigeminal ganglion cells through an RNase L-dependent pathway
    Carr, DJJ
    Al-Khatib, K
    James, CM
    Silverman, R
    JOURNAL OF NEUROIMMUNOLOGY, 2003, 141 (1-2) : 40 - 46
  • [3] Topical application of the cornea post-infection with plasmid DNA encoding interferon-α1 but not recombinant interferon-αA reduces herpes simplex virus type 1-induced mortality in mice
    Noisakran, S
    Carr, DJJ
    JOURNAL OF NEUROIMMUNOLOGY, 2001, 121 (1-2) : 49 - 58
  • [4] Complement Suppresses the Initial Type 1 Interferon Response to Ocular Herpes Simplex Virus Type 1 Infection in Mice
    Carr, Daniel J. J.
    Filiberti, Adrian
    Gmyrek, Grzegorz B.
    PATHOGENS, 2024, 13 (01):
  • [5] Herpes Simplex Virus Type 1 MicroRNAs: An Update
    Duan, Yongzhong
    Sun, Le
    Li, Qihan
    INTERVIROLOGY, 2023, 66 (01) : 97 - 110
  • [6] Study of interferon-β antiviral activity against Herpes simplex virus type 1 in neuron-enriched trigeminal ganglia cultures
    Maria Low-Calle, Ana
    Prada-Arismendy, Jeanette
    Castellanos, Jaime E.
    VIRUS RESEARCH, 2014, 180 : 49 - 58
  • [7] Autocrine interferon-β stimulation augments nitric oxide production by mouse macrophage J774A.1 cells infected with herpes simplex virus type 1
    Fujioka, N
    Ohashi, K
    Ikeda, M
    Kurimoto, M
    MICROBIOLOGY AND IMMUNOLOGY, 2000, 44 (04) : 283 - 287
  • [8] Omeprazole Increases the Efficacy of Acyclovir Against Herpes Simplex Virus Type 1 and 2
    Michaelis, Martin
    Kleinschmidt, Malte C.
    Bojkova, Denisa
    Rabenau, Holger F.
    Wass, Mark N.
    Cinatl, Jindrich, Jr.
    FRONTIERS IN MICROBIOLOGY, 2019, 10
  • [9] Induction of Interferon-λ Contributes to Toll-Like Receptor 3-Mediated Herpes Simplex Virus Type 1 Inhibition in Astrocytes
    Li, Jieliang
    Ye, Li
    Wang, Xu
    Hu, Shuxian
    Ho, Wenzhe
    JOURNAL OF NEUROSCIENCE RESEARCH, 2012, 90 (02) : 399 - 406
  • [10] Herpes Simplex Virus Type 2 Is More Difficult to Neutralize by Antibodies Than Herpes Simplex Virus Type 1
    Heilingloh, Christiane Silke
    Lull, Christopher
    Kleiser, Elissa
    Alt, Mira
    Schipper, Leonie
    Witzke, Oliver
    Trilling, Mirko
    Eis-Huebinger, Anna-Maria
    Dittmer, Ulf
    Krawczyk, Adalbert
    VACCINES, 2020, 8 (03) : 1 - 11